Literature DB >> 7734331

Cocaine hepatotoxicity: a study on the pathogenesis of periportal necrosis.

C J Powell1, S J Charles, J Mullervy.   

Abstract

Cocaine is reported to produce either periportal or mid-zonal necrosis in mice pretreated with the enzyme inducer phenobarbitone (James et al. 1987; Powell et al. 1991; Charles & Powell 1992). Dose-response and time course experiments were performed in phenobarbitone treated male DBA/2Ha mice to study the pathogenesis of this unusual cocaine induced lesion. An increase in the dose of cocaine from 60 to 90 or 120 mg/kg produced more extensive and severe periportal and linking portal damage and elevated plasma aspartate (AST) and alanine (ALT) aminotransferases in a dose dependent manner. Scattered hepatocyte degeneration began at the edge of the periportal region and was detectable by electron microscopy within 30 minutes of administration of 60 mg/kg of cocaine, with conspicuous disorganization of the endoplasmic reticulum being one of the earliest changes. Significant elevations of plasma AST and ALT were observed 3 hours after cocaine administration and were sustained for 12 hours, at which time progressive hepatocyte damage had developed into a network of confluent necrosis at the periphery of the periportal region. The rapidity of organelle derangement and subsequent cell death, and absence of any effect on total cytochrome P-450 or FAD-mono-oxygenase levels, appear to distinguish this periportal lesion from previous reports of cocaine induced centrilobular necrosis in non-enzyme induced mice, suggesting that the two types of damage may develop by different mechanisms. The observation that periportal lesions commence at the periphery of the periportal area, progressing portalwards with increasing dose and time, offers an explanation for the previously conflicting reports of cocaine induced mid-zonal and/or periportal lesions in phenobarbitone treated mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7734331      PMCID: PMC2001918     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  25 in total

1.  Sex and strain differences in response to cocaine.

Authors:  M L Thompson; L Shuster; E Casey; G C Kanel
Journal:  Biochem Pharmacol       Date:  1984-04-15       Impact factor: 5.858

2.  Cocaine-induced hepatotoxicity in mice.

Authors:  M A Evans; R D Harbison
Journal:  Toxicol Appl Pharmacol       Date:  1978-09       Impact factor: 4.219

3.  Demonstration by in situ hybridization of the zonal modulation of rat liver cytochrome P-450b and P-450e gene expression after phenobarbital.

Authors:  E Wojcik; C Dvorak; J Chianale; P G Traber; D Keren; J J Gumucio
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

4.  On the mechanism of butylated hydroxytoluene-induced hepatic toxicity in rats.

Authors:  Y Nakagawa; K Tayama; T Nakao; K Hiraga
Journal:  Biochem Pharmacol       Date:  1984-08-15       Impact factor: 5.858

5.  Antagonism of cocaine-induced hepatotoxicity by the alpha adrenergic antagonists phentolamine and yohimbine.

Authors:  R C James; M A Schiefer; S M Roberts; R D Harbison
Journal:  J Pharmacol Exp Ther       Date:  1987-08       Impact factor: 4.030

6.  Effects of calcium channel blocking agents on calcium and centrilobular necrosis in the liver of rats treated with hepatotoxic agents.

Authors:  E J Landon; R J Naukam; B V Rama Sastry
Journal:  Biochem Pharmacol       Date:  1986-02-15       Impact factor: 5.858

7.  Cocaine-induced hepatotoxicity in humans.

Authors:  L E Perino; G H Warren; J S Levine
Journal:  Gastroenterology       Date:  1987-07       Impact factor: 22.682

8.  Ultrastructure of experimental cocaine hepatotoxicity.

Authors:  M R Gottfried; M W Kloss; D Graham; E J Rauckman; G M Rosen
Journal:  Hepatology       Date:  1986 Mar-Apr       Impact factor: 17.425

9.  Metabolism of norcocaine, N-hydroxy norcocaine and cocaine-N-oxide in the rat.

Authors:  A L Misra; R B Pontani; N L Vadlamani
Journal:  Xenobiotica       Date:  1979-03       Impact factor: 1.908

10.  Comparison of the short-term effects of di(2-ethylhexyl) phthalate, di(n-hexyl) phthalate, and di(n-octyl) phthalate in rats.

Authors:  A H Mann; S C Price; F E Mitchell; P Grasso; R H Hinton; J W Bridges
Journal:  Toxicol Appl Pharmacol       Date:  1985-01       Impact factor: 4.219

View more
  3 in total

1.  Mitochondrial involvement in cocaine-treated rat hepatocytes: effect of N-acetylcysteine and deferoxamine.

Authors:  A Zaragoza; C Díez-Fernández; A M Alvarez; D Andrés; M Cascales
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  Acute renal failure, thrombocytopenia, and elevated liver enzymes after concurrent abuse of alcohol and cocaine.

Authors:  Alireza Hosseinnezhad; Rajakrishnan Vijayakrishnan; Mary Jo S Farmer
Journal:  Clin Pract       Date:  2011-05-16

3.  Reversible Fulminant Hepatitis Secondary to Cocaine in the Setting of β-Blocker Use.

Authors:  Rohan Sharma; Nidhi Kapoor; Kaustubh Suresh Chaudhari; Robert Hal Scofield
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.